My wife, a younger, fit, otherwise healthy person diagnosed with CLL (unmutated IGHV, 11q deletion) began a Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia (iFCR) at Dana Farber in Boston. She just completed 1st month of treatment with remarkable results showing no side affects. WBC down from 50,000 to 6,000, "walnut sized" lymph nodes in neck now undetectable, "lime sized" nodes in abdomen that distended stomach "looking pregnant" reduced to point where her stomach is now flat. We begin 2nd of six monthly 3-day FCR infusions in two days, Ibrutinib pill continues daily for 8-month trial duration. We are optimistic that she will meet goal of trial, MRD negativity 2-months post treatment. She is sharing her treatment experience via webcast on Patient Power web site: patientpower.eu/videos/lead...
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.